Understanding barriers to using arteriovenous fistulas in black patients on dialysis
Barriers to arteriovenous fistula use in black hemodialysis patients
This study is looking into why black patients with kidney failure are less likely to use a certain type of access for dialysis compared to white patients, and it aims to gather insights from both patients and healthcare providers to help improve care for everyone.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-10551916 on NIH RePORTER |
What this research studies
This research investigates the reasons why black patients with end-stage renal disease (ESRD) are less likely to use arteriovenous fistulas (AVFs) for dialysis compared to white patients. It aims to identify patient, provider, and systemic factors that contribute to these disparities. By conducting interviews and surveys, the study will gather insights from patients and healthcare providers about their experiences and perceptions regarding AVF use. The findings will help inform strategies to improve vascular access planning and care for black patients on dialysis.
Who could benefit from this research
Good fit: Ideal candidates for this research are black patients with end-stage renal disease who are undergoing hemodialysis.
Not a fit: Patients who are not undergoing hemodialysis or do not have end-stage renal disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved access to life-saving dialysis treatments for black patients by addressing the barriers to AVF use.
How similar studies have performed: Previous research has highlighted disparities in healthcare access and outcomes, suggesting that addressing these barriers could lead to significant improvements in patient care.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Allon, Michael — University of Alabama at Birmingham
- Study coordinator: Allon, Michael
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.